Detalles de la búsqueda
1.
Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies.
Lancet
; 401(10383): 1159-1171, 2023 04 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36871574
2.
Randomised trial and open-label extension study of an anti-interleukin-6 antibody in Crohn's disease (ANDANTE I and II).
Gut
; 68(1): 40-48, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29247068
3.
Phase II evaluation of anti-MAdCAM antibody PF-00547659 in the treatment of Crohn's disease: report of the OPERA study.
Gut
; 67(10): 1824-1835, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28982740
4.
Anti-MAdCAM antibody (PF-00547659) for ulcerative colitis (TURANDOT): a phase 2, randomised, double-blind, placebo-controlled trial.
Lancet
; 390(10090): 135-144, 2017 07 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28527704
5.
Anrukinzumab, an anti-interleukin 13 monoclonal antibody, in active UC: efficacy and safety from a phase IIa randomised multicentre study.
Gut
; 64(6): 894-900, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25567115
6.
A pharmacokinetic comparison of anrukinzumab, an anti- IL-13 monoclonal antibody, among healthy volunteers, asthma and ulcerative colitis patients.
Br J Clin Pharmacol
; 80(1): 101-9, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25614144
7.
Neoplastic malignant cord compression mimicking low back pain: A case report.
Physiother Res Int
; 28(1): e1971, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36068933
8.
Physiotherapy Screening for Referral of a Patient with Patent Foramen Ovale Presenting with Neck Pain as Primary Complaint: A Case Report.
Healthcare (Basel)
; 11(8)2023 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37107999
9.
Efficacy and safety of olorinab, a full agonist of the cannabinoid receptor 2, for the treatment of abdominal pain in patients with irritable bowel syndrome: Results from a phase 2b randomized placebo-controlled trial (CAPTIVATE).
Neurogastroenterol Motil
; 35(5): e14539, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36740814
10.
Efficacy and Safety of the Anti-Mucosal Addressin Cell Adhesion Molecule-1 Antibody Ontamalimab in Patients with Moderate-to-Severe Ulcerative Colitis or Crohn's Disease.
J Crohns Colitis
; 2023 Dec 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38096402
11.
The Safety, Tolerability, Pharmacokinetics and Clinical Efficacy of the NLRX1 agonist NX-13 in Active Ulcerative Colitis: Results of a Phase 1b Study.
J Crohns Colitis
; 2023 Nov 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37952114
12.
Long-Term Safety and Efficacy of the Anti-Mucosal Addressin Cell Adhesion Molecule-1 Monoclonal Antibody Ontamalimab (SHP647) for the Treatment of Crohn's Disease: The OPERA II Study.
Inflamm Bowel Dis
; 28(7): 1034-1044, 2022 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34427633
13.
Assessing Cranial Nerves in Physical Therapy Practice: Findings from a Cross-Sectional Survey and Implication for Clinical Practice.
Healthcare (Basel)
; 9(10)2021 Sep 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34682942
14.
Craniopharyngioma in a young woman with symptoms presenting as mechanical neck pain associated with cervicogenic headache: a case report.
Physiother Theory Pract
; 37(4): 549-558, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-31271335
15.
Long-term Safety and Efficacy of the Anti-MAdCAM-1 Monoclonal Antibody Ontamalimab [SHP647] for the Treatment of Ulcerative Colitis: The Open-label Study TURANDOT II.
J Crohns Colitis
; 15(6): 938-949, 2021 Jun 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-33599720
16.
Hip bone marrow edema presenting as low back pain: a case report.
Physiother Theory Pract
; 36(1): 249-257, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-29856266
17.
Anti-MAdCAM-1 antibody (PF-00547659) for active refractory Crohn's disease in Japanese and Korean patients: the OPERA study.
Intest Res
; 18(1): 45-55, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32013314
18.
Molecular Profiling of Ulcerative Colitis Subjects from the TURANDOT Trial Reveals Novel Pharmacodynamic/Efficacy Biomarkers.
J Crohns Colitis
; 13(6): 702-713, 2019 May 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-30901380
19.
Targeting Endothelial Ligands: ICAM-1/alicaforsen, MAdCAM-1.
J Crohns Colitis
; 12(suppl_2): S669-S677, 2018 Aug 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-29757363
20.
Anti-MAdCAM Antibody Increases ß7+ T Cells and CCR9 Gene Expression in the Peripheral Blood of Patients With Crohn's Disease.
J Crohns Colitis
; 12(1): 77-86, 2018 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28961803